Recordati Industria Chimica e Farmaceutica S.p.A. (REC)
MTA
Closed
Oct 5, 2026
Day's Range
52.2052 wk Range
43.76Overview - REC - Recordati Industria Chimica e Farmaceutica S.p.A.
Key Statistics
Valuation
Enterprise Value
12.77B
P/E (Trailing)
22.26
P/E (Forward)
14.09
PEG Ratio
14.09
Price / Sales (TTM)
4.07
Price / Book
5.09
EV / EBITDA
12.59
Profitability
Gross Margin
71.40%
Profit Margin
18.37%
Operating Margin
29.19%
Return on Assets
9.77%
Return on Equity
24.85%
Ownership
Shares Outstanding
204.81M
Float
101.82M
Held by Insiders
46.82%
Held by Institutions
32.20%
Price stats
Beta
0.50
50-Day Avg
52.58
200-Day Avg
50.11
Dividends
Payout Ratio
56.29%
Frequency
Semi-Annual
Analyst Consensus
8 analysts
Average price target
€ 59.26Market Cap - REC - Recordati Industria Chimica e Farmaceutica S.p.A.
Peers - REC - Recordati Industria Chimica e Farmaceutica S.p.A.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
- RECMTARecordati Industria Chimica e Farmaceutica S.p.A.10.07BMarket Cap+1.42%52-week change22.27P/E (Trailing)18.37%Profit Margin
- 1LLYMTAEli Lilly and Company853.56BMarket Cap+33.43%52-week change39.84P/E (Trailing)33.52%Profit Margin
- 1JNJMTAJohnson & Johnson428.46BMarket Cap+29.05%52-week change30.89P/E (Trailing)21.48%Profit Margin
- 1ABBVMTAAbbVie Inc.344.57BMarket Cap+15.69%52-week change76.30P/E (Trailing)9.80%Profit Margin
- 1ROMTARoche Holding AG294.63BMarket Cap+18.28%52-week change23.90P/E (Trailing)19.60%Profit Margin
- 1MRKXMTAMerck & Co., Inc.240.41BMarket Cap+42.65%52-week change117.80P/E (Trailing)4.76%Profit Margin
- 1NOVNMTANovartis AG Registered Shares238.75BMarket Cap+11.75%52-week change22.04P/E (Trailing)22.50%Profit Margin
Profile Summary - REC - Recordati Industria Chimica e Farmaceutica S.p.A.
About
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical company specializing in the development, manufacturing, and commercialization of innovative medicines across specialty and primary care, consumer healthcare, and rare diseases. Headquartered in Milan, Italy, it traces its origins to a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
